Back to APGE
WELLINGTON MANAGEMENT GROUP LLP → APGE
WELLINGTON MANAGEMENT GROUP LLP APGE Position History
Apogee Therapeutics Inc • Healthcare
Quarters held
22
Latest value
$2.3M
Q2 2026
Peak value
$332M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $324.7M |
| Q4 2025 | $1.6M |
| Q4 2025 | $383K |
| Q4 2025 | $3.3M |
| Q4 2025 | $20.2M |
| Q4 2025 | $117K |
| Q4 2025 | $8M |
| Q1 2026 | $332M |
| Q1 2026 | $2M |
| Q1 2026 | $31K |
| Q1 2026 | $665K |
| Q1 2026 | $3.5M |
| Q1 2026 | $20.8M |
| Q1 2026 | $108K |
| Q1 2026 | $9.3M |
| Q2 2026 | $48.3M |
| Q2 2026 | $2.7M |
| Q2 2026 | $275K |
| Q2 2026 | $3M |
| Q2 2026 | $18.3M |
| Q2 2026 | $137K |
| Q2 2026 | $2.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $2.3M | 17.3K | — | — |
| Q2 2026 | $137K | 1.0K | — | — |
| Q2 2026 | $18.3M | 137.7K | — | — |
| Q2 2026 | $3M | 22.5K | — | — |
| Q2 2026 | $275K | 2.1K | — | — |
| Q2 2026 | $2.7M | 20.1K | — | — |
| Q2 2026 | $48.3M | 363.6K | — | — |
| Q1 2026 | $9.3M | 110.0K | — | — |
| Q1 2026 | $108K | 1.3K | — | — |
| Q1 2026 | $20.8M | 247.1K | — | — |
| Q1 2026 | $3.5M | 41.1K | — | — |
| Q1 2026 | $665K | 7.9K | — | — |
| Q1 2026 | $31K | 364 | — | — |
| Q1 2026 | $2M | 23.8K | — | — |
| Q1 2026 | $332M | 3.94M | — | — |
| Q4 2025 | $8M | 106.6K | — | — |
| Q4 2025 | $117K | 1.5K | — | — |
| Q4 2025 | $20.2M | 267.7K | — | — |
| Q4 2025 | $3.3M | 43.7K | — | — |
| Q4 2025 | $383K | 5.1K | — | — |
| Q4 2025 | $1.6M | 20.7K | — | — |
| Q4 2025 | $324.7M | 4.30M | — | — |
Other funds holding APGE
$1.1B
$714.9M
$641.1M
$534.2M
$424M
$378.3M
$378.3M